CJC-1295 with Dac 5mg

CJC-1295 with DAC 5mg

CJC-1295 with DAC (Long-Acting GHRH)

CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH). The addition of the Drug Affinity Complex (DAC) fundamentally alters its pharmacokinetic profile by allowing the molecule to bind to blood serum albumin. In research settings, this binding significantly extends the peptide's half-life from mere minutes to several days, resulting in a continuous, sustained release of Growth Hormone and IGF-1, rather than the natural pulsatile release seen with standard GHRH analogues.

Why Researchers Choose Perth Peptides

Due to the extended duration of action of the DAC formulation, purity and stability are critical to avoid unintended experimental variables over a prolonged study period. Our CJC-1295 with DAC is synthesised to pharmaceutical-grade standards in a GMP-compliant facility. Every batch is subjected to independent HPLC testing to ensure a minimum purity of 99%, providing researchers with a highly stable and reliable endocrine agent.

Product Highlights

• Purity: ≥99% (independently verified)
• Mechanism: Sustained GHRH receptor agonist
• Half-Life: Extended (up to 8 days in animal models due to albumin binding)
• Use: Designed for long-term endocrine, IGF-1, and sustained growth hormone secretion research.
• Form: White lyophilised powder for extended stability.

Storage

Keep sealed and stored dry at 2–8 °C away from direct light. For long-term storage, store at -20°C. Once reconstituted with Bacteriostatic Water, refrigerate and use within 4 weeks.

Disclaimer: This product is provided strictly for laboratory and research use only. It is not intended for human consumption, diagnostic, or therapeutic use. By purchasing, you confirm you are a qualified researcher handling this material in compliance with all applicable regulations.